Anti-tumour necrosis factor (TNF)-alpha therapy (etanercept) down-regulates serum matrix metalloproteinase (MMP)-3 and MMP-1 in rheumatoid arthritis (Q40640392)
Jump to navigation
Jump to search
scientific article published on May 2002
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Anti-tumour necrosis factor (TNF)-alpha therapy (etanercept) down-regulates serum matrix metalloproteinase (MMP)-3 and MMP-1 in rheumatoid arthritis |
scientific article published on May 2002 |
Statements
1 reference
Anti-tumour necrosis factor (TNF)-alpha therapy (etanercept) down-regulates serum matrix metalloproteinase (MMP)-3 and MMP-1 in rheumatoid arthritis (English)
1 reference
1 reference
Catrina AI
1 reference
Lampa J
1 reference
Ernestam S
1 reference
af Klint E
1 reference
Bratt J
1 reference
Ulfgren AK
1 reference
1 May 2002
1 reference
1 reference
41
1 reference
5
1 reference
484-489
1 reference
Identifiers
1 reference
1 reference